Skip to main content

Research Repository

Advanced Search

Prognostic, diagnostic and therapeutic potential of endothelial progenitor cells for patients with ischaemic stroke: Hype or Hope

Bayraktutan, Ulvi

Prognostic, diagnostic and therapeutic potential of endothelial progenitor cells for patients with ischaemic stroke: Hype or Hope Thumbnail


Authors



Abstract

Ischaemic stroke is a debilitating disease with immense personal, societal and economic impact. Thrombolysis with recombinant tissue plasminogen activator remains the only approved pharmacotherapy for this disease. As each year less than 1% of eligible patients receive this therapy worldwide, efficacious new therapeutics are desperately needed. Emerging evidence suggest endothelial progenitor cells (EPCs), capable of repairing damaged vasculature, as one such therapeutics. However, questions regarding their optimal dose, delivery route and in vivo survivability remain largely unanswered. Outgrowth endothelial cells, generated in large numbers by ex vivo expansion of EPCs, enable effective assessment of these issues and may eventually serve as off-the-shelf therapeutics. Correlations between circulating EPC levels and stroke outcome imply that EPCs may also serve as clinical biomarkers for stroke. This viewpoint briefly evaluates the current evidence, pinpoints the gaps in the literature and proposes new directions for research.

Citation

Bayraktutan, U. (2022). Prognostic, diagnostic and therapeutic potential of endothelial progenitor cells for patients with ischaemic stroke: Hype or Hope. Biocell, 46(7), 1593-1598. https://doi.org/10.32604/biocell.2022.018679

Journal Article Type Article
Acceptance Date Aug 23, 2021
Online Publication Date Jan 5, 2022
Publication Date Mar 17, 2022
Deposit Date Sep 30, 2021
Publicly Available Date Sep 30, 2021
Journal Biocell
Print ISSN 0327-9545
Electronic ISSN 1667-5746
Publisher Computers, Materials and Continua (Tech Science Press)
Peer Reviewed Peer Reviewed
Volume 46
Issue 7
Pages 1593-1598
DOI https://doi.org/10.32604/biocell.2022.018679
Keywords Ischaemic stroke; Endothelial Progenitor Cells; Stroke therapeutics; Clinical biomarkers; Regenerative medicine
Public URL https://nottingham-repository.worktribe.com/output/6347793
Publisher URL https://www.techscience.com/biocell/online/detail/18351